ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

VIZYFLORA+

Product Packing: 20X1.5 GM

Product Composition: Prebiotic & Probiotic sachet (Premium FOS)

Product Price: MRP : 360

VIZYFLORA+

Prebiotic & Probiotic Sachet (Premium FOS) | SACHET 20 X 1.5 GM

VIZYFLORA+ is a prebiotic and probiotic sachet presented with Premium FOS (fructooligosaccharides) in a 1.5 gm sachet pack. The supplied product brief does not provide the probiotic strain names, CFU counts, FOS quantity, other ingredients or serving directions; therefore, these details have not been invented or inferred.

Probiotics are live microorganisms that may provide health benefits when administered in adequate amounts, while FOS is a prebiotic carbohydrate that can be utilized by selected beneficial gut microorganisms. Product-specific benefits depend on the exact strains, viable counts, prebiotic quantity, stability and approved claims.

Composition

Each approved 1.5 gm sachet contains:

·         Prebiotic component - Premium FOS (exact quantity not supplied)

·         Probiotic component - exact strain(s) and viable CFU count(s) not supplied

·         Other ingredients / excipients - not supplied. Exact FOS quantity, probiotic strain identity, CFU count at manufacture and/or end of shelf life, allergen information and complete formulation must be verified from the current approved product label.

Dosage form: Prebiotic & Probiotic Sachet

Pack size: 20 X 1.5 gm

Uses of VIZYFLORA+

VIZYFLORA+ may be used as a prebiotic-probiotic nutritional/gut-microbiota support product only to the extent supported by its verified strain-specific composition, approved claims and current label.

·         May help support a balanced intestinal microbiota when the included probiotic strains are present in adequate viable amounts

·         FOS may serve as a prebiotic substrate for selected beneficial intestinal microorganisms

·         May support digestive well-being according to the verified formulation and approved product claims

·         Strain-specific claims such as support during antibiotic use, bowel regularity or particular gastrointestinal conditions should not be made unless supported by the actual strains, evidence and approved label

Persistent diarrhea, blood in stool, high fever, dehydration, severe abdominal pain, unexplained weight loss or prolonged gastrointestinal symptoms require professional assessment.

How VIZYFLORA+ Works

VIZYFLORA+ combines a prebiotic concept with probiotic microorganisms:

Premium FOS: Fructooligosaccharides are nondigestible carbohydrates that reach the colon and can be fermented by selected intestinal microorganisms.

Probiotics: Live microorganisms may support gut microbial balance when the specific strains are administered in adequate viable quantities.

The effects of probiotics are strain-specific; benefits demonstrated for one strain or dose should not automatically be attributed to another.

The final effect also depends on viable CFU count, product stability, storage conditions, FOS quantity, diet and individual gastrointestinal factors.

Exact product-specific mechanisms and benefits should therefore be based on the verified VIZYFLORA+ strain composition and approved claims.

 

Dosage and Direction for Use

Use VIZYFLORA+ only according to the current approved product label or healthcare professional's advice. Dose, frequency, age suitability and duration must not be inferred because the strain composition, CFU counts and FOS quantity were not supplied.

Open the sachet immediately before use and administer or mix only as directed on the approved label.

If mixing with food or liquid is permitted, follow the label's temperature and preparation instructions because excessive heat may reduce probiotic viability.

Follow the specified storage conditions carefully. Probiotic viability can be affected by heat, moisture and improper storage.

Possible Side Effects

Possible effects may include:

·         Temporary gas, bloating or abdominal fullness, particularly when starting a prebiotic/probiotic product

·         Mild changes in bowel habits may occur in some individuals

·         FOS can cause increased gas, bloating or loose stools depending on the quantity and individual tolerance

·         Allergic or intolerance reactions may occur depending on the exact probiotic culture media, excipients or other ingredients

·         Serious probiotic-associated infection is uncommon but has been reported mainly in severely immunocompromised, critically ill or otherwise high-risk individuals.

·         Stop use and seek medical advice for severe or persistent gastrointestinal symptoms, allergic reaction, fever or signs of systemic illness.

Precautions and Contraindications

·         Avoid use in patients with known hypersensitivity to any verified ingredient, probiotic strain, culture medium residue or excipient in the formulation.

·         Use caution and obtain professional advice in severely immunocompromised or critically ill patients, patients with central venous catheters, or other individuals at increased risk of invasive infection.

·         Probiotic suitability in premature infants, neonates and medically fragile children requires specific professional and product-label review.

·         Patients with significant gastrointestinal disease, severe acute pancreatitis or serious systemic illness should use probiotic products only under appropriate medical guidance.

·         FOS may worsen gas or bloating in sensitive individuals; tolerance depends on the actual quantity per sachet.

·         Pregnancy, breastfeeding and pediatric use should follow the approved label and professional advice.

·         Check the exact probiotic strains, CFU counts, FOS quantity, allergens, storage requirements, shelf-life viability specification and age recommendations on the approved label.

·         Keep out of reach of children and protect the sachets from heat and moisture as directed.

·         Drug Interaction Considerations

·         Antibiotics can reduce the viability of susceptible probiotic bacteria if taken together. Where relevant, dose separation may be advised, but the appropriate interval depends on the exact strains, antibiotic and approved product directions.

·         Antifungal medicines may affect probiotic yeast strains if any are present. Because the exact VIZYFLORA+ strains were not supplied, interaction advice must be finalized after verifying the composition.

Business Growth Opportunity with VIZYFLORA+

VIZYFLORA+ offers pharmaceutical and healthcare distributors an opportunity to add a Premium FOS-based prebiotic and probiotic sachet to an appropriately licensed gastrointestinal and nutritional-support portfolio.

Promotion must remain strictly consistent with the verified probiotic strains, CFU counts, FOS quantity, approved nutritional/health claims, age range, storage requirements and applicable regulations.

 

Key Business Advantages

·         Prebiotic + Probiotic sachet concept with Premium FOS

·         Convenient unit-dose 1.5 gm sachet format

·         Suitable for a gut-health and nutritional-support portfolio subject to verified formulation and approved claims

·         Pack of 20 X 1.5 gm sachets

·         Product positioning can be tailored to the verified strain profile and approved regulatory claims

·         Opportunity for ethical promotion through appropriate healthcare and wellness channels

PCD Pharma Franchise Opportunity for VIZYFLORA+

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for VIZYFLORA+ in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with verified and approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical and nutritional-support portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for VIZYFLORA+ and other quality-focused healthcare products.

Third-Party Manufacturing Support for Prebiotic & Probiotic Sachets

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of prebiotic-probiotic sachets similar to VIZYFLORA+ under their own brand, subject to applicable licensing, regulatory, stability and manufacturing requirements.

Our third-party manufacturing support may include:

·         Verified formulation and 1.5 gm sachet pack configuration support, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities with appropriate probiotic handling and quality controls

·         Support for documentation, stability specifications and applicable regulatory requirements

This service may be suitable for eligible businesses seeking to expand an appropriately licensed gastrointestinal and nutritional-support portfolio.

Frequently Asked Questions About VIZYFLORA+

1. What is VIZYFLORA+?

VIZYFLORA+ is described in the supplied product brief as a Prebiotic & Probiotic Sachet with Premium FOS, packed as 20 X 1.5 gm sachets.

2. What is FOS?

FOS stands for fructooligosaccharides, nondigestible carbohydrates commonly used as prebiotics because selected beneficial intestinal microorganisms can ferment them.

3. Which probiotic strains are present in VIZYFLORA+?

The strain names and CFU counts were not supplied. These must be verified from the approved formulation and current product label before making strain-specific claims.

4. What does a probiotic do?

Specific probiotic strains may support gut microbial balance when administered in adequate viable amounts. Benefits are strain- and dose-specific.

5. Can VIZYFLORA+ be taken with antibiotics?

Some probiotics are used during antibiotic therapy, but timing and suitability depend on the exact strains and antibiotic. Follow the approved label or healthcare professional's advice.

6. How should VIZYFLORA+ be used and stored?

Use and store it exactly as stated on the approved label. Avoid unapproved exposure to heat or moisture because probiotic viability may be reduced.

7. Is a PCD Pharma Franchise available for VIZYFLORA+?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can a similar sachet be manufactured under my own brand?

Eligible businesses may explore third-party manufacturing and private-label support for similar prebiotic-probiotic sachets, subject to verified strain/CFU specifications, stability, licensing, manufacturing and regulatory requirements.

Disclaimer

VIZYFLORA+ product information in this document is for general professional and business information. The supplied product brief states only 'Prebiotic & Probiotic sachet (Premium FOS)', SACHET 20 X 1.5 GM. Probiotic strain names, CFU counts, Premium FOS quantity, other ingredient quantities, allergens, culture-medium details, approved claims, dose/frequency, age range and storage conditions were not supplied and have not been invented or inferred. The complete approved formulation, strain-specific evidence, viable-count specification, approved claims, directions, warnings, manufacturing/stability specifications, regulatory status and labeling must be verified against the current approved product documents before manufacture, promotion, recommending, dispensing or use. This document is not a substitute for professional medical advice.

Contact